封面
市場調查報告書
商品編碼
2149743

寵物焦慮緩解和鎮靜產品市場預測(2034 年)—按產品類型、寵物品種、分銷管道和地區分類的全球分析

Pet Anxiety and Calming Products Market Forecasts to 2034 - Global Analysis By Product Type, Pet Type, Distribution Channel, and By Geography

出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球寵物焦慮緩解和鎮靜產品市場預計到 2026 年將達到 180 億美元,並在預測期內以 3.8% 的複合年成長率成長,到 2034 年達到 242 億美元。

寵物焦慮緩解和鎮靜產品旨在減輕伴侶動物的壓力、焦慮和行為問題,從而改善它們的健康和生活品質。該市場涵蓋多種產品類型,例如鎮靜補充劑、信息素產品、鎮靜穿戴設備、鎮靜玩具、外用鎮靜產品以及其他鎮靜產品。這些產品透過獸醫診所、寵物專賣店、超級市場和量販店、線上零售以及其他分銷管道銷售給犬、貓和其他寵物。人們對寵物心理健康的日益關注、寵物「擬人化」趨勢的增強以及寵物焦慮相關症狀的日益普遍,是推動市場擴張的主要因素。

人們越來越關注寵物心理健康和焦慮問題

人們對伴侶動物心理健康問題以及焦慮對寵物福祉影響的認知不斷提高,是推動寵物焦慮和鎮靜產品市場發展的主要動力。寵物飼主越來越關注寵物出現的壓力和焦慮徵兆。分離焦慮和噪音恐懼症症等行為問題困擾著許多寵物。隨著寵物越來越“擬人化”,人們對它們的情感健康也日益關注。這種對寵物心理健康日益增強的意識正在擴大對鎮靜產品的需求,從而支撐著市場的持續成長。

有效性證據有限,且有懷疑態度。

某些鎮靜劑產品缺乏科學證據,消費者對其療效持懷疑態度,這是限制市場發展的主要阻礙因素。並非所有產品都有可靠的臨床證據。一些消費者可能對天然鎮靜劑持懷疑態度。此外,其療效可能因動物而異。這些挑戰,例如缺乏科學證據和消費者的懷疑態度,可能會限制某些產品類型的市場成長。

天然來源且經臨床驗證的鎮靜成分創新

天然來源且經臨床驗證的鎮靜成分的持續創新為市場擴張帶來了巨大的機會。 L-茶胺酸、洋甘菊和CBD等成分正日益受到歡迎,支持其有效性的臨床研究也不斷增加。新的劑型提高了使用便利性。隨著產品品質和科學證據的不斷完善,創新鎮靜產品正在擴大其市場佔有率。

行為訓練和獸藥競爭

行為訓練和處方箋獸藥的競爭對寵物焦慮和鎮靜產品市場構成重大威脅。行為訓練有時無需使用這些產品即可解決行為問題。對於嚴重的焦慮,處方箋藥可能是更好選擇。這些替代方案可能會限制非處方鎮靜產品的市場成長。

新型冠狀病毒(COVID-19)的影響:

新冠疫情擾亂了寵物們的日常生活,隨著飼主重返職場,寵物焦慮和鎮靜產品的市場需求加速成長。飼主重返辦公室後,寵物的分離焦慮情緒也隨之加劇。人們對寵物心理健康的關注度不斷提高,鎮靜產品的電商銷售額也隨之成長。即使在疫情結束後,人們對寵物福祉的關注依然持續,推動了市場成長。

在預測期內,「鎮靜劑補充劑」細分市場預計將佔據最大的市場佔有率。

在預測期內,「鎮靜補充劑」細分市場預計將佔據最大的市場佔有率,這主要得益於其易於獲取、劑型多樣以及消費者對天然鎮靜劑日益成長的偏好。鎮靜補充劑,包括咀嚼片、片劑和粉末,為緩解寵物焦慮提供了便利的選擇。此細分市場受益於產品供應量的增加和消費者意識的提高。作為最容易取得的鎮靜產品類型,補充劑在產品類型細分市場中佔據最大佔有率。

預計在預測期內,「狗」類產品將呈現最高的複合年成長率。

在預測期內,受犬隻數量龐大、犬隻焦慮症高發以及飼主對犬隻心理健康意識不斷提高等因素的推動,犬類市場預計將呈現最高的成長率。犬隻普遍有分離焦慮、噪音恐懼症和情境性壓力等問題。犬類市場受益於針對犬隻的廣泛產品開發。隨著犬隻飼養量和焦慮症意識的提高,預計犬隻將成為該細分市場中成長最快的寵物犬種。

市佔率最大的地區:

在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於較高的寵物擁有率、對寵物心理健康的高度重視以及成熟的產品供應。美國是該地區成長的主要驅動力,這主要歸功於消費者在寵物鎮靜劑上的巨額支出。人們對寵物焦慮問題的高度關注也推動了市場需求。成熟的零售和電商通路為市場准入提供了支援。憑藉高消費和高認知度,北美在市場中保持主導地位。

複合年成長率最高的地區:

在預測期內,受寵物飼養量成長、寵物心理健康意識提升以及產品在歐洲各國供應範圍擴大等因素的推動,歐洲地區預計將呈現最高的複合年成長率。歐洲寵物飼主越來越關注寵物的福祉。產品創新和供應也不斷擴展。隨著這種意識的增強,歐洲在寵物焦慮緩解和鎮靜產品市場正經歷全球最快的成長。

免費客製化服務:

所有購買此報告的客戶均可享受以下免費自訂選項之一:

  • 企業概況
    • 對其他市場參與者(最多 3 家公司)進行全面分析
    • 對主要公司進行SWOT分析(最多3家公司)
  • 區域細分
    • 根據客戶的興趣,我們將提供主要國家的市場估算和預測,以及複合年成長率(註:需經可行性確認)。
  • 競爭性標竿分析
    • 根據產品系列、企業發展和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章:研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章:競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章:全球寵物焦慮緩解與鎮靜產品市場:依產品類型分類

  • 鎮靜劑
    • 咀嚼玩具和零食
    • 片劑和膠囊
    • 粉末
    • 液體補充劑
  • 含信息素的產品
    • 擴散器
    • 噴霧和霧化
    • 衣領
  • 具有鎮靜效果的穿戴式產品
    • 緩解焦慮的裹布和背心
    • 鎮靜項圈
  • 放鬆玩具
  • 局部鎮靜劑產品
  • 其他鎮靜劑產品

第6章:全球寵物焦慮緩解與鎮靜產品市場:依寵物類型分類

  • 狗
  • 貓
  • 其他寵物

第7章:全球寵物焦慮緩解和鎮靜產品市場:按分銷管道分類

  • 獸醫醫院和獸醫醫療機構
  • 寵物專賣店
  • 超級市場和量販店
  • 線上零售
  • 其他分銷管道

第8章:全球寵物焦慮緩解和鎮靜產品市場:按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區(RoW)
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第9章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第10章:產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第11章:公司簡介

  • Nestle Purina PetCare
  • Mars, Incorporated
  • Zoetis Inc.
  • Virbac SA
  • Elanco Animal Health Incorporated
  • Ceva Sante Animale
  • PetIQ, LLC
  • Zesty Paws
  • PetHonesty
  • Vetoquinol SA
  • NaturVet
  • THUNDERWORKS
  • Pet Remedy Ltd.
  • Feliway
  • PetSafe Brands
Product Code: SMRC40182

According to Stratistics MRC, the Global Pet Anxiety and Calming Products Market is accounted for $18.0 billion in 2026 and is expected to reach $24.2 billion by 2034 growing at a CAGR of 3.8% during the forecast period. Pet anxiety and calming products are solutions designed to reduce stress, anxiety, and behavioral issues in companion animals, improving their well-being and quality of life. The market encompasses product types including calming supplements, pheromone-based products, calming wearables, calming toys, topical calming products, and other calming products. These products serve dogs, cats, and other pets through veterinary clinics and hospitals, pet specialty stores, supermarkets and mass retailers, online retail, and other distribution channels. Growing awareness of pet mental health, increasing pet humanization, and rising prevalence of anxiety-related conditions in pets are key drivers of market expansion.

Market Dynamics:

Driver:

Growing awareness of pet mental health and anxiety issues

The increasing recognition of mental health issues in companion animals and the impact of anxiety on pet well-being is a primary driver for the pet anxiety and calming products market. Pet owners are increasingly aware of signs of stress and anxiety in their animals. Behavioral issues including separation anxiety and noise phobias affect many pets. The humanization of pets has led to greater focus on emotional well-being. As awareness of pet mental health grows, demand for calming products expands, supporting sustained market growth.

Restraint:

Limited efficacy evidence and skepticism

Limited scientific evidence for some calming products and consumer skepticism about efficacy represent a major restraint for the market. Not all products have robust clinical evidence. Some consumers may be skeptical of natural calming remedies. Efficacy can vary between individual animals. These evidence and skepticism challenges may constrain market growth for certain product categories.

Opportunity:

Innovation in natural and clinically validated calming ingredients

Continuous innovation in natural and clinically validated calming ingredients presents significant opportunities for market expansion. Ingredients including L-theanine, chamomile, and CBD are gaining popularity. Clinical studies supporting efficacy are increasing. Novel delivery formats improve convenience. As product quality and evidence improve, innovative calming products capture growing market share.

Threat:

Competition from behavioral training and veterinary medications

Competition from behavioral training approaches and prescription veterinary medications poses significant threats to the pet anxiety and calming products market. Training may address behavioral issues without products. Prescription medications may be preferred for severe anxiety. These alternatives may limit market growth for over-the-counter calming products.

Covid-19 Impact:

The COVID-19 pandemic accelerated pet anxiety and calming products market growth as pets experienced routine disruptions and owners returned to work. Separation anxiety increased as owners returned to offices. Awareness of pet mental health grew. E-commerce sales of calming products expanded. Post-pandemic, continued focus on pet well-being has supported market growth.

The Calming Supplements segment is expected to be the largest during the forecast period

The Calming Supplements segment is expected to account for the largest market share during the forecast period, driven by their accessibility, variety of formats, and growing consumer preference for natural calming solutions. Calming supplements including chews, tablets, and powders offer convenient options for managing pet anxiety. The segment benefits from expanding product availability and consumer awareness. As the most accessible calming product category, supplements maintain the largest product type segment share.

The Dogs segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Dogs segment is predicted to witness the highest growth rate, fueled by the large dog population, high prevalence of anxiety in dogs, and growing owner awareness of canine mental health. Dogs commonly experience separation anxiety, noise phobias, and situational stress. The segment benefits from extensive product development for dogs. As dog ownership and anxiety awareness grow, this pet type delivers the fastest segment growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership, strong awareness of pet mental health, and established product availability. The United States leads regional growth with substantial consumer spending on pet calming products. High awareness of pet anxiety issues drives demand. Well-established retail and e-commerce channels support market accessibility. With high spending and awareness, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Europe region is anticipated to exhibit the highest CAGR, driven by increasing pet ownership, growing awareness of pet mental health, and expanding product availability across European countries. European pet owners are increasingly focused on pet well-being. Product innovation and availability are expanding. As awareness grows, Europe delivers the fastest pet anxiety and calming products market growth globally.

Key players in the market

Some of the key players in Pet Anxiety and Calming Products Market include Nestle Purina PetCare, Mars, Incorporated, Zoetis Inc., Virbac S.A., Elanco Animal Health Incorporated, Ceva Sante Animale, PetIQ, LLC, Zesty Paws, PetHonesty, Vetoquinol S.A., NaturVet, THUNDERWORKS, Pet Remedy Ltd., Feliway, and PetSafe Brands.

Key Developments:

In September 2026, Ceva Animal Health expanded its welfare initiative with Cats Protection across the United Kingdom, linking FELIWAY Optimum sales directly to sheltering and behavioral enrichment programs for surrendered cats showing severe anxiety.

In July 2026, Vetoquinol USA officially introduced Zylkene Plus across the United States, expanding its alpha-casozepine-based calming line with a dual-active formula designed for longer-term management of chronic environmental stress and behavioral anxiety in dogs and cats.

In February 2026, Nestle Purina PetCare convened global veterinary behaviorists and animal welfare scientists at the Purina Pro Plan Calming Care Symposium, presenting clinical research on modulating the canine gut-brain axis and highlighting regulatory milestones for the BL999 probiotic strain.

In January 2026, Elanco secured USDA approval for TruCan Ultra B (Oral), collaborating with the Fear Free movement to market low-volume, low-stress preventive administration formats aimed at reducing fear, anxiety, and clinic-induced distress in dogs.

Product Types Covered:

  • Calming Supplements
  • Pheromone-Based Products
  • Calming Wearables
  • Calming Toys
  • Topical Calming Products
  • Other Calming Products

Pet Types Covered:

  • Dogs
  • Cats
  • Other Pets

Distribution Channels Covered:

  • Veterinary Clinics and Hospitals
  • Pet Specialty Stores
  • Supermarkets and Mass Retailers
  • Online Retail
  • Other Distribution Channels

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Pet Anxiety and Calming Products Market, By Product Type

  • 5.1 Calming Supplements
    • 5.1.1 Chews and Treats
    • 5.1.2 Tablets and Capsules
    • 5.1.3 Powders
    • 5.1.4 Liquid Supplements
  • 5.2 Pheromone-Based Products
    • 5.2.1 Diffusers
    • 5.2.2 Sprays and Mists
    • 5.2.3 Collars
  • 5.3 Calming Wearables
    • 5.3.1 Anxiety Wraps and Vests
    • 5.3.2 Calming Collars
  • 5.4 Calming Toys
  • 5.5 Topical Calming Products
  • 5.6 Other Calming Products

6 Global Pet Anxiety and Calming Products Market, By Pet Type

  • 6.1 Dogs
  • 6.2 Cats
  • 6.3 Other Pets

7 Global Pet Anxiety and Calming Products Market, By Distribution Channel

  • 7.1 Veterinary Clinics and Hospitals
  • 7.2 Pet Specialty Stores
  • 7.3 Supermarkets and Mass Retailers
  • 7.4 Online Retail
  • 7.5 Other Distribution Channels

8 Global Pet Anxiety and Calming Products Market, By Geography

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 United Kingdom
    • 8.2.2 Germany
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Spain
    • 8.2.6 Netherlands
    • 8.2.7 Belgium
    • 8.2.8 Sweden
    • 8.2.9 Switzerland
    • 8.2.10 Poland
    • 8.2.11 Rest of Europe
  • 8.3 Asia Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 South Korea
    • 8.3.5 Australia
    • 8.3.6 Indonesia
    • 8.3.7 Thailand
    • 8.3.8 Malaysia
    • 8.3.9 Singapore
    • 8.3.10 Vietnam
    • 8.3.11 Rest of Asia Pacific
  • 8.4 South America
    • 8.4.1 Brazil
    • 8.4.2 Argentina
    • 8.4.3 Colombia
    • 8.4.4 Chile
    • 8.4.5 Peru
    • 8.4.6 Rest of South America
  • 8.5 Rest of the World (RoW)
    • 8.5.1 Middle East
      • 8.5.1.1 Saudi Arabia
      • 8.5.1.2 United Arab Emirates
      • 8.5.1.3 Qatar
      • 8.5.1.4 Israel
      • 8.5.1.5 Rest of Middle East
    • 8.5.2 Africa
      • 8.5.2.1 South Africa
      • 8.5.2.2 Egypt
      • 8.5.2.3 Morocco
      • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

  • 9.1 Industry Value Network and Supply Chain Assessment
  • 9.2 White-Space and Opportunity Mapping
  • 9.3 Product Evolution and Market Life Cycle Analysis
  • 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

  • 10.1 Mergers and Acquisitions
  • 10.2 Partnerships, Alliances, and Joint Ventures
  • 10.3 New Product Launches and Certifications
  • 10.4 Capacity Expansion and Investments
  • 10.5 Other Strategic Initiatives

11 Company Profiles

  • 11.1 Nestle Purina PetCare
  • 11.2 Mars, Incorporated
  • 11.3 Zoetis Inc.
  • 11.4 Virbac S.A.
  • 11.5 Elanco Animal Health Incorporated
  • 11.6 Ceva Sante Animale
  • 11.7 PetIQ, LLC
  • 11.8 Zesty Paws
  • 11.9 PetHonesty
  • 11.10 Vetoquinol S.A.
  • 11.11 NaturVet
  • 11.12 THUNDERWORKS
  • 11.13 Pet Remedy Ltd.
  • 11.14 Feliway
  • 11.15 PetSafe Brands

List of Tables

  • Table 1 Global Pet Anxiety and Calming Products Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Pet Anxiety and Calming Products Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Pet Anxiety and Calming Products Market Outlook, By Calming Supplements (2023-2034) ($MN)
  • Table 4 Global Pet Anxiety and Calming Products Market Outlook, By Chews and Treats (2023-2034) ($MN)
  • Table 5 Global Pet Anxiety and Calming Products Market Outlook, By Tablets and Capsules (2023-2034) ($MN)
  • Table 6 Global Pet Anxiety and Calming Products Market Outlook, By Powders (2023-2034) ($MN)
  • Table 7 Global Pet Anxiety and Calming Products Market Outlook, By Liquid Supplements (2023-2034) ($MN)
  • Table 8 Global Pet Anxiety and Calming Products Market Outlook, By Pheromone-Based Products (2023-2034) ($MN)
  • Table 9 Global Pet Anxiety and Calming Products Market Outlook, By Diffusers (2023-2034) ($MN)
  • Table 10 Global Pet Anxiety and Calming Products Market Outlook, By Sprays and Mists (2023-2034) ($MN)
  • Table 11 Global Pet Anxiety and Calming Products Market Outlook, By Collars (2023-2034) ($MN)
  • Table 12 Global Pet Anxiety and Calming Products Market Outlook, By Calming Wearables (2023-2034) ($MN)
  • Table 13 Global Pet Anxiety and Calming Products Market Outlook, By Anxiety Wraps and Vests (2023-2034) ($MN)
  • Table 14 Global Pet Anxiety and Calming Products Market Outlook, By Calming Collars (2023-2034) ($MN)
  • Table 15 Global Pet Anxiety and Calming Products Market Outlook, By Calming Toys (2023-2034) ($MN)
  • Table 16 Global Pet Anxiety and Calming Products Market Outlook, By Topical Calming Products (2023-2034) ($MN)
  • Table 17 Global Pet Anxiety and Calming Products Market Outlook, By Other Calming Products (2023-2034) ($MN)
  • Table 18 Global Pet Anxiety and Calming Products Market Outlook, By Pet Type (2023-2034) ($MN)
  • Table 19 Global Pet Anxiety and Calming Products Market Outlook, By Dogs (2023-2034) ($MN)
  • Table 20 Global Pet Anxiety and Calming Products Market Outlook, By Cats (2023-2034) ($MN)
  • Table 21 Global Pet Anxiety and Calming Products Market Outlook, By Other Pets (2023-2034) ($MN)
  • Table 22 Global Pet Anxiety and Calming Products Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 23 Global Pet Anxiety and Calming Products Market Outlook, By Veterinary Clinics and Hospitals (2023-2034) ($MN)
  • Table 24 Global Pet Anxiety and Calming Products Market Outlook, By Pet Specialty Stores (2023-2034) ($MN)
  • Table 25 Global Pet Anxiety and Calming Products Market Outlook, By Supermarkets and Mass Retailers (2023-2034) ($MN)
  • Table 26 Global Pet Anxiety and Calming Products Market Outlook, By Online Retail (2023-2034) ($MN)
  • Table 27 Global Pet Anxiety and Calming Products Market Outlook, By Other Distribution Channels (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW)

Regions are also represented in the same manner as above.